Human Genome Sciences, Inc. (NASDAQ: HGSI) announced a secondary offering last night of up to 12.5 million shares. This now looks further and further as though it is dwindling as a takeover candidate. This would raise over $300 million. It is safe to assume that trading volume will pick up as we get closer to the opening bell. At 8:10 AM EST there have only been 7,000 shares traded and the stock is down over 3% at $26.95 this morning. We saw this one down at $26.50 last night.